[{"Assets_0_Q3_USD":518903000.0,"CommonStockSharesOutstanding_0_Q3_shares":51554479.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-67867000.0,"NetIncomeLoss_1_Q3_USD":-50711000.0,"NetIncomeLoss_3_Q3_USD":-117391000.0,"StockholdersEquity_0_Q3_USD":417314000.0,"Ticker":"CRSP","CIK":"1674416","name":"CRISPR THERAPEUTICS AG","OfficialName":"CRISPR Therapeutics AG Common Shares","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4543904930.0","Country":"Switzerland","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20181107"}]